Teva Pharmaceuticals Ne (teva 3.15 10/01/26)
13F holders, Q1 2025 (March 31)1holders
$0.97avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Teva Pharmaceuticals Ne (teva 3.15 10/01/26) in their 13F filings. The largest holder was Pacer Advisors, Inc. ($222K).
- Company
- Teva Pharmaceuticals Ne (teva 3.15 10/01/26)
- CUSIP
- 88167AAE1
- Latest filing quarter
- Q1 2025
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $222K |
| Exits | 0 | $0 |
Ownership 1 holders
| Pacer Advisors, Inc. | 0.00% | New | 229,000 | $222K |
"% of holder's portfolio" is TEVA PHARMACEUTICALS NE (TEVA 3.15 10/01/26)'s weight in each manager's 13F, not the share of Teva Pharmaceuticals Ne (teva 3.15 10/01/26) the manager owns.